The English High Court has handed down a mixed ruling in a dispute between Edwards Lifesciences and its competitor Meril Life Sciences.
Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.
Police in Mumbai and Hyderabad have arrested 14 people on suspicion of distributing black market remdesivir at five times its retail price.
IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.
Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
The World Health Organization and Costa Rica will launch a technology pooling initiative to help fight the COVID-19 pandemic.
Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office.
India has imposed export restrictions on drugs and active pharmaceutical ingredients (APIs), including paracetamol, amid fears over COVID-19-related shortages.
Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.